Cytochrome P450 single nucleotide polymorphisms in an indigenous Tanzanian population: a concern about the metabolism of artemisinin-based combinations-Reference-Cited by-同舟云学术

Cytochrome P450 single nucleotide polymorphisms in an indigenous Tanzanian population: a concern about the metabolism of artemisinin-based combinations

Published:2014-11-03 Issue:1 Volume:13 Page:
ISSN:1475-2875
Container-title:Malaria Journal
language:en
Short-container-title:Malar J

Author:

Marwa Karol J,Schmidt Theresa,Sjögren Maria,Minzi Omary MS,Kamugisha Erasmus,Swedberg Göte

Publisher

Springer Science and Business Media LLC

Subject

Infectious Diseases,Parasitology

Link

http://link.springer.com/content/pdf/10.1186/1475-2875-13-420.pdf

Reference61 articles.

1. Kerb R, Fux R, Morike K, Kremsner PG, Gil JP, Gleiter CH, Schwab M: Pharmacogenetics of antimalarial drugs: effect on metabolism and transport. Lancet Infect Dis. 2009, 9: 760-774. 10.1016/S1473-3099(09)70320-2.

2. Obua C, Hellgren U, Ntale M, Gustafsson LL, Ogwal-Okeng JW, Gordi T, Jerling M: Population pharmacokinetics of chloroquine and sulfadoxine and treatment response in children with malaria: suggestions for an improved dose regimen. Br J Clin Pharmacol. 2008, 65: 493-501. 10.1111/j.1365-2125.2007.03050.x.

3. Arav-Boger R, Shapiro TA: Molecular mechanisms of resistance in antimalarial chemotherapy: the unmet challenge. Annu Rev Pharmacol Toxicol. 2005, 45: 565-585. 10.1146/annurev.pharmtox.45.120403.095946.

4. Shah RR: Pharmacogenetics in drug regulation: promise, potential and pitfalls. Philos Trans R Soc Lond B Biol Sci. 2005, 360: 1617-1638. 10.1098/rstb.2005.1693.

5. Seripa D, Pilotto A, Panza F, Matera MG: Pharmacogenetics of cytochrome P450 (CYP) in the elderly. Ageing Res Rev. 2010, 9: 457-474. 10.1016/j.arr.2010.06.001.

Cited by 26 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Genetic variation present in the CYP3A4 gene in Ni-Vanuatu and Kenyan populations in malaria endemicity;Drug Metabolism and Pharmacokinetics;2024-08

2. The Influence of Cytochrome P450 Polymorphisms on Pharmacokinetic Profiles and Treatment Outcomes Among Malaria Patients in Sub-Saharan Africa: A Systematic Review;Pharmacogenomics and Personalized Medicine;2023-05

3. Human Cytochrome P450 1, 2, 3 Families as Pharmacogenes with Emphases on Their Antimalarial and Antituberculosis Drugs and Prevalent African Alleles;International Journal of Molecular Sciences;2023-02-08

4. Biomarkers of the Toxic Effects of Chemotherapeutic Agents: A Focus on Antimalarials;Biomarkers in Toxicology;2023

5. Genetic variability (785A > G, 516G > T and 64C > T) in the CYP2B6 gene among individuals in Southwest Nigeria: Implications for malaria treatment;Human Gene;2022-12